Scholars Central

Review articlePublished 12 Mar 2020

Management of no-reflow: Still an unsolved problem?

Authors: Aless, Ro M, Urino-mirizzi, Marcello Spolverini, Andrea Attanasio, Gabriele Crimi

Journal of Phlebology and Lymphology

Volume 13 · Issue 1 · Pages 1–7

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

No-reflow represents an important limitation of percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Importantly, no-reflow is associated with an increased risk of major adverse cardiac events. In this review, we discuss the pharmacological and nonpharmacological interventions proposed for the prevention and treatment of no-reflow, highlighting the new updates and evidences on efficacy of these approaches.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Phlebology and Lymphology.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Phlebology and Lymphology
  • SubjectCardiology
  • BylineArticles whose byline prints “Aless”
  • BylineArticles whose byline prints “Ro M”
  • BylineArticles whose byline prints “Urino-mirizzi”
  • BylineArticles whose byline prints “Marcello Spolverini”
  • BylineArticles whose byline prints “Andrea Attanasio”
  • BylineArticles whose byline prints “Gabriele Crimi”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels